Amphastar Pharma (NASDAQ: AMPH) reported Q3 EPS of $0.12, $0.01 better than the analyst estimate of $0.11. Revenue for the quarter came in at $75.5 million versus the consensus estimate of $74.73 million.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.